Nuveen Asset Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.51M Sell
2024
Q3
$2.08M Buy
2024
Q2
$1.75M Buy
2024
Q1
$810K Sell
2023
Q4
$1.21M Buy
2023
Q3
$1.16M Buy
2023
Q2
$860K Buy
2023
Q1
$188K Buy
2022
Q2
Sell
2022
Q1
$130K Hold
2021
Q4
$237K Buy